ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "E25: MAINRITSAN 2 - Fixed vs. Tailored Rituxan for AAV "
Episode Synopsis
Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!
More episodes of the podcast The Evidence Based Rheumatology Podcast
E130: Telitacicept for SLE
22/12/2025
E127: TNFs and All That CHF
22/09/2025
E126: Risk Signals, JAKs, and SELECTIVE-ity
08/09/2025
E122: Guidelines for Maybe Diagnosing HLH
17/04/2025
E121: Obinutuzumab in SLE-LN
02/04/2025
In God we trust